Company intelligence / Profile preview
PHARAONIA Pharmaceuticals
Cairo, Cairo Governorate, Egyptpharaoniapharma.com ↗
- Ownership
- Private
- Employees
- ~2000
- Development stage
- Commercial
01
Overview
PHARAONIA Pharmaceuticals has over 250 products on the market and more than 50 in its pipeline. The company’s portfolio spans nearly all major therapeutic areas and dosage forms. It focuses on generic pharmaceuticals with a strong presence in Egypt and exports to over thirty countries. No specific clinical trial results are disclosed publicly.
- Therapeutic areas
- Men's HealthWomen's HealthPsychiatryDermatologyRheumatologyCardiovascularOphthalmologyInfectious Diseases
- Modalities
- Small molecules (tablets, capsules, syrups, solutions)
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on PHARAONIA Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PHARAONIA Pharmaceuticals.